Definium Therapeutics (DFTX) Change in Cash (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly Change in Cash of $4.7 million for Q1 2026, up 102.45% year-over-year from $2.3 million in Q1 2025, and down 98.03% quarter-over-quarter from $237.9 million in Q4 2025.
Definium Therapeutics (DFTX) Change in Cash (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Change in Cash for 6 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 102.45% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $179.7 million (up 206.01% YoY), while the FY2025 annual figure was -$15.9 million, down 109.14% from the prior year.
- Change in Cash retreated to $4.7 million in Q1 2026 per DFTX's latest filing, from $237.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $237.9 million in Q4 2025 and bottomed at -$190.9 million in Q1 2025.
- Historically, Change in Cash has averaged $7.6 million across 5 years, with a median of -$12.5 million in 2023.
- Annual changes were most pronounced in 2024 — Change in Cash soared 6386.57% — and 2025, when it slumped 437.63%.
- Definium Therapeutics' Change in Cash stood at -$12.4 million in 2022, then tumbled by 45.39% to -$18.0 million in 2023, then fell by 19.72% to -$21.5 million in 2024, then soared by 1204.2% to $237.9 million in 2025, then plunged by 98.03% to $4.7 million in 2026.
- Business Quant data shows DFTX's Change in Cash at $4.7 million in Q1 2026, $237.9 million in Q4 2025, and -$13.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - | 392.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 392.75 Mn |
| Mar 31, 2026 | 4.68 Mn |
| Dec 31, 2025 | 237.88 Mn |
| Sep 30, 2025 | -13.43 Mn |
| Jun 30, 2025 | -49.46 Mn |
| Mar 31, 2025 | -190.89 Mn |
| Dec 31, 2024 | -21.54 Mn |
| Sep 30, 2024 | 52.15 Mn |
| Jun 30, 2024 | -9.20 Mn |
| Mar 31, 2024 | 152.63 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | 804,000.00 |
| Jun 30, 2023 | -12.51 Mn |
| Mar 31, 2023 | -12.73 Mn |
| Dec 31, 2022 | -12.38 Mn |
| Sep 30, 2022 | 48.78 Mn |
| Jun 30, 2022 | -14.73 Mn |
| Mar 31, 2022 | -13.07 Mn |
| Dec 31, 2021 | -12.38 Mn |
| Sep 30, 2021 | -11.18 Mn |